Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma
Systemic sclerosis (SSc), or scleroderma, is a connective tissue disorder characterized by progressive fibrosis of the skin and internal organs. It has significance for gastroenterologists because the gastrointestinal tract is involved in 90% of SSc patients, who often present with esophageal dysfun...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2004/458271 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562284852936704 |
|---|---|
| author | Jennifer M Raoul Monica Verma Ernest Tan Theresa C Peterson |
| author_facet | Jennifer M Raoul Monica Verma Ernest Tan Theresa C Peterson |
| author_sort | Jennifer M Raoul |
| collection | DOAJ |
| description | Systemic sclerosis (SSc), or scleroderma, is a connective tissue disorder characterized by progressive fibrosis of the skin and internal organs. It has significance for gastroenterologists because the gastrointestinal tract is involved in 90% of SSc patients, who often present with esophageal dysfunction. Though the exact pathogenesis of SSc is unknown, there is increasing evidence supporting an immune mechanism. Cytokines are the soluble mediators of immune activation, altered fibroblast proliferation and extracellular matrix accumulation in SSc and thereby provide important therapeutic targets. In the present review, the involvement of cytokines in SSc is discussed with particular emphasis on cytokines and growth factors that have been implicated in the disease process and likely play an important role in the gastrointestinal manifestations of scleroderma. The role of cytokines as therapeutic targets in scleroderma forms the basis of this timely review |
| format | Article |
| id | doaj-art-c14ad462dff142f68952675e92941db5 |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2004-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-c14ad462dff142f68952675e92941db52025-02-03T01:23:05ZengWileyCanadian Journal of Gastroenterology0835-79002004-01-01181222410.1155/2004/458271Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of SclerodermaJennifer M Raoul0Monica Verma1Ernest Tan2Theresa C Peterson3Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaDepartment of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, CanadaSystemic sclerosis (SSc), or scleroderma, is a connective tissue disorder characterized by progressive fibrosis of the skin and internal organs. It has significance for gastroenterologists because the gastrointestinal tract is involved in 90% of SSc patients, who often present with esophageal dysfunction. Though the exact pathogenesis of SSc is unknown, there is increasing evidence supporting an immune mechanism. Cytokines are the soluble mediators of immune activation, altered fibroblast proliferation and extracellular matrix accumulation in SSc and thereby provide important therapeutic targets. In the present review, the involvement of cytokines in SSc is discussed with particular emphasis on cytokines and growth factors that have been implicated in the disease process and likely play an important role in the gastrointestinal manifestations of scleroderma. The role of cytokines as therapeutic targets in scleroderma forms the basis of this timely reviewhttp://dx.doi.org/10.1155/2004/458271 |
| spellingShingle | Jennifer M Raoul Monica Verma Ernest Tan Theresa C Peterson Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma Canadian Journal of Gastroenterology |
| title | Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma |
| title_full | Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma |
| title_fullStr | Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma |
| title_full_unstemmed | Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma |
| title_short | Cytokines as Therapeutic Targets for the Gastrointestinal Manifestations of Scleroderma |
| title_sort | cytokines as therapeutic targets for the gastrointestinal manifestations of scleroderma |
| url | http://dx.doi.org/10.1155/2004/458271 |
| work_keys_str_mv | AT jennifermraoul cytokinesastherapeutictargetsforthegastrointestinalmanifestationsofscleroderma AT monicaverma cytokinesastherapeutictargetsforthegastrointestinalmanifestationsofscleroderma AT ernesttan cytokinesastherapeutictargetsforthegastrointestinalmanifestationsofscleroderma AT theresacpeterson cytokinesastherapeutictargetsforthegastrointestinalmanifestationsofscleroderma |